EU Prepares Ground For Deployment Of COVID-19 Vaccines
Plans Include Vaccination Priorities, Safety Studies And Tackling Mistrust
Executive Summary
With the number of COVID-19 cases continuing to rise across Europe, the European Commission executive has published a set of actions to be taken at EU and national level to ensure future vaccines are allocated fairly, targeted at priority populations, and labeled in a way that increases production capacity, reduces transport costs and improves distribution.
You may also be interested in...
Coronavirus Notebook: Pfizer/BioNTech & Russian Vaccines Each Claim Efficacy Of More than 90%
As data start to come in on the first coronavirus vaccines, hopes are rising that vaccination campaigns will be able to begin in the next month or two, although experts have cautioned against unbridled optimism. Uncertainties also remain over questions such as whom to vaccinate first and how to assure equitable access in less wealthy parts of the world.
Pressure Group Undaunted By EU Refusal To Disclose COVID-19 Vaccine Contracts
The European Commission has dismissed attempts by pressure groups to secure access to details of COVID-19 vaccine deals negotiated with pharmaceutical firms. The Corporate Europe Observatory says it is “disappointed” by the decision but is not giving up the chase.
Coronavirus Notebook: EU Strikes Deals For Gilead’s Veklury, Janssen’s Vaccine
Russia is planning to register a second COVID-19 vaccine this month, while the UK is ramping up its manufacturing capacity for vaccines and therapeutics.